349 related items for PubMed ID: 19391484
1. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
Wagrowska-Danilewicz M, Danilewicz M.
Pol J Pathol; 2008; 59(4):189-94. PubMed ID: 19391484
[Abstract] [Full Text] [Related]
2. Correlative insights into the immunoexpression of transforming growth factor beta-1 in acutely rejected renal allografts.
Danilewicz M, Wagrowska-Danilewicz M.
Pathol Res Pract; 2006; 202(1):9-15. PubMed ID: 16343799
[Abstract] [Full Text] [Related]
3. Dysregulation of immunoexpression of matrix metalloproteinases in renal chronic allograft injury.
Wagrowska-Danilewicz M, Danilewicz M.
Pol J Pathol; 2009; 60(2):88-93. PubMed ID: 19886183
[Abstract] [Full Text] [Related]
4. Correlative insights into immunoexpression of monocyte chemoattractant protein-1, transforming growth factor beta-1 and CD68+ cells in lupus nephritis.
Wagrowska-Danilewicz M, Stasikowska O, Danilewicz M.
Pol J Pathol; 2005; 56(3):115-20. PubMed ID: 16334978
[Abstract] [Full Text] [Related]
5. Expression and response to angiotensin-converting enzyme inhibition of matrix metalloproteinases 2 and 9 in renal glomerular damage in young transgenic rats with renin-dependent hypertension.
Bolbrinker J, Markovic S, Wehland M, Melenhorst WB, van Goor H, Kreutz R.
J Pharmacol Exp Ther; 2006 Jan; 316(1):8-16. PubMed ID: 16166267
[Abstract] [Full Text] [Related]
6. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
Ermolli M, Schumacher M, Lods N, Hammoud M, Marti HP.
Transpl Immunol; 2003 Jan; 11(2):137-45. PubMed ID: 12799196
[Abstract] [Full Text] [Related]
7. Immunohistochemical analysis of transforming growth factor beta-1 in AA and AL renal amyloidosis.
Danilewicz M, Wagrowska-Danilewicz M.
Pol J Pathol; 2006 Jan; 57(4):193-8. PubMed ID: 17285762
[Abstract] [Full Text] [Related]
8.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
9. Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.
Sanders JS, van Goor H, Hanemaaijer R, Kallenberg CG, Stegeman CA.
Nephrol Dial Transplant; 2004 Jun; 19(6):1412-9. PubMed ID: 15034162
[Abstract] [Full Text] [Related]
10. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
Yang K, Palm J, König J, Seeland U, Rosenkranz S, Feiden W, Rübe C, Rübe CE.
Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
[Abstract] [Full Text] [Related]
11. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA, Taylor PM, Allen SP, Yacoub MH.
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[Abstract] [Full Text] [Related]
12. [Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof].
Zou HQ, Yao J, Wang YX, Wang J, Li D, Wang P.
Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):981-5. PubMed ID: 16061007
[Abstract] [Full Text] [Related]
13. Renal transplant fibrosis correlates with intragraft expression of tissue inhibitor of metalloproteinase messenger RNA.
Nicholson ML, Waller JR, Bicknell GR.
Br J Surg; 2002 Jul 13; 89(7):933-7. PubMed ID: 12081746
[Abstract] [Full Text] [Related]
14. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, Béliveau R.
Transpl Int; 2003 Apr 13; 16(4):262-9. PubMed ID: 12730807
[Abstract] [Full Text] [Related]
15. Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.
Zechel J, Gohil H, Lust WD, Cohen A.
J Neurosci Res; 2002 Sep 01; 69(5):662-8. PubMed ID: 12210832
[Abstract] [Full Text] [Related]
16. Platelet-derived growth factor and transforming growth factor-beta modulate the expression of matrix metalloproteinases and migratory function of human airway smooth muscle cells.
Ito I, Fixman ED, Asai K, Yoshida M, Gounni AS, Martin JG, Hamid Q.
Clin Exp Allergy; 2009 Sep 01; 39(9):1370-80. PubMed ID: 19522858
[Abstract] [Full Text] [Related]
17. Indices of extracellular matrix turnover in human masseter muscles as markers of craniofacial form--a preliminary study.
Tippett HL, Dodgson LK, Hunt NP, Lewis MP.
Eur J Orthod; 2008 Apr 01; 30(2):217-25. PubMed ID: 18263891
[Abstract] [Full Text] [Related]
18. A correlation between immunoexpression of CD44, alpha-SMA and CD68+ cells in IgA-nephropathy and in mesangial proliferative IgA-negative glomerulonephritis.
Wagrowska-Danilewicz M, Danilewicz M.
Pol J Pathol; 2002 Apr 01; 53(3):155-62. PubMed ID: 12476618
[Abstract] [Full Text] [Related]
19. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression.
O'Grady A, Dunne C, O'Kelly P, Murphy GM, Leader M, Kay E.
Histopathology; 2007 Dec 01; 51(6):793-804. PubMed ID: 18042068
[Abstract] [Full Text] [Related]
20. Specific changes in plasma concentrations of matrix metalloproteinase-2 and -9, TIMP-1 and TGF-beta1 in patients with distinct types of primary glomerulonephritis.
Bauvois B, Mothu N, Nguyen J, Nguyen-Khoa T, Nöel LH, Jungers P.
Nephrol Dial Transplant; 2007 Apr 01; 22(4):1115-22. PubMed ID: 17205957
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
